Pain Management Devices Market

Pain Management Devices Market, by Type (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, and Ablation Devices), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), by End User (Hospitals, Clinics, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Pain management devices include those for cancer pain, nociceptive pain, musculoskeletal pain, and others. There are many different kinds of pain treatment equipment on the market, including ablation devices, transcutaneous electrical nerve stimulators, analgesic infusion pumps, and spinal cord stimulators. These devices work by targeting the source of pain and providing relief through various methods, such as blocking pain signals or releasing medication directly to the affected area. It is important to consult with a healthcare professional to determine the best pain management device for individual needs and conditions. Costly and invasive implantable devices should only be utilized as effective treatments when less aggressive and expensive ones have failed to relieve pain and suffering. When used for the correct reasons by the right people, spinal cord stimulation neuromodulates neuropathic pain signals but not nociceptive pain signals. This results in roughly 60–80% long-term pain alleviation in patients who were tested for efficacy.

Market Dynamics

Devices for neuromodulation are primarily used to treat and reduce the symptoms of neurological illnesses', such as pain, epilepsy, tremor, stroke, etc. Additionally, neuromodulation devices are usedto treat a variety of illnesses linked to aging and neurotic conditions. The prevalence of neurological illnesses is increasing, non-opioid treatments are becoming more popular, and neurostimulation devices provide a variety of advantages, all of which contribute to the market's expansion.

Key features of the study:

• This report provides an in-depth analysis of the global pain management devices market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, technology advancement, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pain management devices market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Stryker Corporation, Pfizer Inc. (Hospira Inc.), Medtronic Plc, Boston Scientific Corporation, Baxter International Inc., Braun Melsungen AG, Abbott Laboratories, Colfax Corporation (Djo Global LLC), Kimberly-Clark Corporation (Baylis Medical), Johnson & Johnson (Codman and Shurtleff, Inc.), Neuspera Medical, ZetrOZ Systems, Therabody, BioElectronics Corporation, Nevro Corp, Stevanato Group S.p.A., Bexson Biomedical, Inc., SPR Therapeutics, Lumaflex, Saluda Medical Pty Limited, DyAnsys Inc., Pacira BioSciences, Inc., InterSystems, Nalu Medical, Inc., and StimaWELL North America Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global pain management devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain management devices market

Detailed Segmentation:

• Global Pain Management Devices Market, By Type:
• Neuromodulation & Neurostimulation Devices
• Analgesic Infusion Pumps
• Ablation Devices
• Global Pain Management Devices Market, By Application:
• Neuropathic Pain
• Cancer Pain
• Facial & Migraine Pain
• Musculoskeletal Pain
• Others
• Global Pain Management Devices Market, By End User:
• Hospitals
• Clinics
• Others
• Global Pain Management Devices Market, By Region:
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC
• Israel
• Rest of Middle East
• Africa
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Stryker Corporation
• Pfizer Inc. (Hospira Inc.)
• Medtronic Plc
• Boston Scientific Corporation
• Baxter International Inc.
• Braun Melsungen AG
• Abbott Laboratories
• Colfax Corporation (Djo Global LLC)
• Kimberly-Clark Corporation (Baylis Medical)
• Johnson & Johnson (Codman and Shurtleff, Inc.)
• Neuspera Medical
• ZetrOZ Systems
• Therabody Inc.
• BioElectronics Corporation
• Nevro Corp
• Stevanato Group S.p.A.
• Bexson Biomedical, Inc
• SPR Therapeutics
• Lumaflex
• Saluda Medical Pty Limited
• DyAnsys Inc
• Pacira BioSciences, Inc.
• InterSystems
• Nalu Medical, Inc.
• StimaWELL North America Inc.